Editorial on Pfizer + It’s time to levy p... - Cure Parkinson's

Cure Parkinson's

25,515 members26,825 posts

Editorial on Pfizer + It’s time to levy penalties for failing to report clinical trial results

MBAnderson profile image
1 Reply

Good one.

scienceofparkinsons.com/201...

It’s time to levy penalties for failing to report clinical trial results

statnews.com/2018/01/17/tim...

Written by
MBAnderson profile image
MBAnderson
To view profiles and participate in discussions please or .
Read more about...
1 Reply
Juliegrace profile image
Juliegrace

Two excellent articles. Thanks.

You may also like...

Pioneering stem-cell trials in Japan report promising early results

Professor Jun Takahashi is involved in one trial expected to report results soon, in which...

Encouraging results from the CureParkinsons supported Phase II clinical trial of the GLP-1R agonist Liraglutide

uk/2022/04/liraglutide-trial-results/ https://twitter.com/ScienceofPD/status/1511325651944591361

Bayer reports positive early data for Parkinson’s cell therapy

well-tolerated in a 12-person clinical trial....

TUDCA VS. UDCA : Cure Parkinson's UDCA trial ending 2021

https://scienceofparkinsons.com/2018/04/16/udca/ The Cure Parkinson's UDCA trial is scheduled to end

New Stem Cell Trial in Houston Recruiting

stem cell trial for PD recruiting. The PD trials seems to have placebo arms (not a fan of trials...